POST-MARKET SUMMARY 27th March 2024

On March 27, the market rebounded from the previous session's losses, buoyed by purchasing in heavyweight stocks and sectors like auto, realty, power, and capital goods. Top Gainer: RELIANCE | Top Loser: UPL

Liquide Post-Market Summary 27th March 2024

On March 27, the market rebounded from the previous session's losses, buoyed by purchasing in heavyweight stocks and sectors like auto, realty, power, and capital goods. Despite mixed global cues, the market commenced positively and sustained its upward trajectory throughout the day. This momentum was propelled by a narrowed Current Account Deficit (CAD) at $10.5 billion in the third quarter and increased buying in heavyweight stocks. Notably, sectors such as auto, bank, capital goods, power, realty, and telecom saw gains of 0.5-1%, while metal, IT, and media experienced declines of 0.3-0.5%.

NIFTY:  The index opened 49 points higher at 22,053 and made a high of 22,193 before closing at 22,123. Nifty has formed a bullish candlestick pattern with an upper shadow on the daily chart. Its immediate resistance level is now placed at 22,200 while immediate support is at 22,050.

BANK NIFTY: The index opened 43 points higher at 46,643 and closed at 46,785. Bank Nifty has formed a bullish candlestick pattern with an upper shadow on the daily chart. Its immediate resistance level is now placed at 47,000 while support is at 46,350.

Indices closing for 27th March 2024
Major Market Indices data
FII/DII Data
Nifty Gainers & Losers

Stocks in Spotlight

▪  Coal India:  Stock slipped 1% after a large containership crashed into the Baltimore bridge, shutting down the second largest exit point for coal shipments from the US for now.

▪  Wockhardt:  Stock jumped 5% and got locked in the upper circuit after funds managed by ace investors Madhusudan Kela and Prashant Jain invested in the company's Rs 480-crore qualified institutional placement.

▪  Astrazeneca Pharma: Stock gained nearly 4% a day after the company said it received permission from the Central Drugs Standard Control Organisation to import, sell and distribute Trastuzumab deruxtecan lyophilized powder concentrate for solution for infusion 100mg (Enhertu).

Global News

▪  The yen dropped to its lowest level since 1990 on Wednesday, into a zone that triggered intervention by Japanese authorities in 2022, prompting the finance minister to warn Japan would take “decisive steps” against excessive currency moves.

▪  Gold prices edged higher on Wednesday as investors awaited U.S. inflation data that could offer fresh clues about when the Federal Reserve will start easing its monetary policy.

▪  Oil prices fell for a second day on Wednesday on surging U.S. stockpiles and signs that OPEC+ is unlikely to change its output policy at a technical meeting next week.


This document has been issued by Liquide Solutions Private Limited for information purposes only and should not be construed as

i) an offer or recommendation to buy or sell securities, commodities, currencies or other investments referred to herein; or

ii) an offer to sell or a solicitation or an offer for the purchase of any of the baskets of Liquide Solutions; or

iii) investment research or investment advice. It does not have regard to specific investment objectives, financial situation and the particular needs of any specific person who may receive this document. Investors should seek personal and independent advice regarding the appropriateness of investing in any of the funds, securities, other investment, or investment strategies that may have been discussed or referred to herein and should understand that the views regarding future prospects may or may not be realized. In no event shall Liquide Life Private Limited and/or its affiliates or any of their directors, trustees, officers and employees be liable for any direct, indirect, special, incidental or consequential damages arising out of the use of information/opinion herein.

With Liquide, you can explore stocks, trade securely in your own broker account, and receive expert-recommended trade setups. Stay updated with real-time tracking, market commentary, and AI-powered insights from LiMo, our intelligent bot. Whether you're a seasoned investor or a newbie, Liquide provides the tools you need to discover your next big investment opportunity. Download the app now from Google Play Store and Apple App Store to revolutionize your investment journey. Don't miss out on the chance to level up your investing game with Liquide.